NCT00581867View on ClinicalTrials.gov

Memory and Insulin in Early Alzheimer's Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Alzheimer's Disease
Interventions
DRUG

Insulin Aspart

40IU insulin aspart applied intranasally

DRUG

Placebo

Placebo

Trial Locations (1)

66160

University of Kansas Medical Center, Hoglund Brain Imaging Center, Kansas City

All Listed Sponsors
lead

Jeff Burns, MD

OTHER

NCT00581867 - Memory and Insulin in Early Alzheimer's Disease | Biotech Hunter | Biotech Hunter